Search Results - Cara A. Rosenbaum
- Showing 1 - 9 results of 9
-
1
Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma by Andrzej Jakubowiak, Jagoda Jasielec, Cara A. Rosenbaum, Craig E. Cole, Ajai Chari, Joseph Mıkhael, Jennifer Nam, Amanda McIver, Erica Severson, Leonor A Stephens, Kathryn M. Tinari, Shaun Rosebeck, Todd M. Zimmerman, Tyler Hycner, Agata Turowski, Theodore Karrison, Jeffrey A. Zonder
Published 2019Artigo -
2
Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group by Andrea Havasi, Cihan Heybeli, Nelson Leung, Avital Angel-Korman, Vaishali Sanchorawala, Oliver Cohen, Ashutosh Wechalekar, Frank Bridoux, Insara Jaffer, Victoria Gutgarts, Hani Hassoun, Maya Levinson, Cara A. Rosenbaum, Paolo Milani, Giovanni Palladini, Giampaolo Merlini, Ute Hegenbart, Stefan Schönland, Kaya Veelken, Alexander Pogrebinsky, Gheorghe Doros, Heather Landau
Published 2022Artigo -
3
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma by Jagoda Jasielec, Tadeusz Kubicki, Noopur Raje, Ravi Vij, Donna Reece, Jesús G. Berdeja, Benjamin A. Derman, Cara A. Rosenbaum, Paul G. Richardson, Sandeep Gurbuxani, Sarah Major, Brittany Wolfe, Andrew Stefka, Leonor A Stephens, Kathryn M. Tinari, Tyler Hycner, Alexandra E. Rojek, Dominik Dytfeld, Kent A. Griffith, Todd M. Zimmerman, Andrzej Jakubowiak
Published 2020Artigo -
4
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma by Mateo Mejía Saldarriaga, Darren Pan, Caitlin Unkenholz, Tarek H. Mouhieddine, Juan Esteban Velez-Hernandez, Katherine Engles, Joshua Fein, Jorge Monge, Cara A. Rosenbaum, Roger Pearse, David Jayabalan, Christian Gordillo, Hei Ton Chan, Samuel Yamshon, Santiago Thibaud, Markus Y. Mapara, Giorgio Inghirami, Suzanne Lentzsch, Ran Reshef, Adriana Rossi, Samir Parekh, Sundar Jagannath, Shambavi Richard, Rubén Niesvizky, Mark Bustoros
Published 2024Artigo -
5
Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society COVID-19 Dataset by Ajai Chari, Mehmet Samur, Joaquín Martínez‐López, Gordon Cook, Noa Biran, Kwee Yong, Vânia Hungria, Monika Engelhardt, Francesca Gay, Ana García Feria, Stefania Oliva, Rimke Oostvogels, Alessandro Gozzetti, Cara A. Rosenbaum, Shaji Kumar, Edward A. Stadtmauer, Hermann Einsele, Meral Beksaç, Katja Weisel, Kenneth C. Anderson, María‐Victoria Mateos, Philippe Moreau, Jesús F. San Miguel, Nikhil C. Munshi, Hervé Avet‐Loiseau
Published 2020Pré-impressão -
6
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set by Ajai Chari, Mehmet Samur, Joaquín Martínez‐López, Gordon Cook, Noa Biran, Kwee Yong, Vânia Hungria, Monika Engelhardt, Francesca Gay, Ana García Feria, Stefania Oliva, Rimke Oostvogels, Alessandro Gozzetti, Cara A. Rosenbaum, Shaji Kumar, Edward A. Stadtmauer, Hermann Einsele, Meral Beksaç, Katja Weisel, Kenneth C. Anderson, María‐Victoria Mateos, Philippe Moreau, Jesús F. San Miguel, Nikhil C. Munshi, Hervé Avet‐Loiseau
Published 2020Artigo -
7
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers by Malin Hultcrantz, Joshua Richter, Cara A. Rosenbaum, Dhwani Patel, Eric L. Smith, Neha Korde, Sydney X. Lu, Sham Mailankody, Urvi A. Shah, Alexander M. Lesokhin, Hani Hassoun, Carlyn Tan, Francesco Maura, Andriy Derkach, Benjamin Diamond, Adriana Rossi, Roger Pearse, Deepu Madduri, Ajai Chari, David Kaminetzky, Marc Braunstein, Christian Gordillo, Ran Reshef, Ying Taur, Faith E. Davies, Sundar Jagannath, Rubén Niesvizky, Suzanne Lentzsch, Gareth J. Morgan, Ola Landgren
Published 2020Artigo -
8
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma by Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister, David D. Hurd, Hani Hassoun, Paul G. Richardson, Sergio Giralt, Edward A. Stadtmauer, Daniel J. Weisdorf, Ravi Vij, Jan S. Moreb, Natalie S. Callander, Koen van Besien, Teresa Gentile, Luis Isola, Richard T. Maziarz, Don A. Gabriel, Asad Bashey, Heather Landau, Thomas G. Martin, Muzaffar H. Qazilbash, Denise Levitan, Brian McClune, Robert Schlossman, Vera Hárs, John Postiglione, Chen Jiang, Elizabeth Bennett, Susan Barry, Linda R. Bressler, Michael E. Kelly, Michele Seiler, Cara A. Rosenbaum, Parameswaran Hari, Marcelo C. Pasquini, Mary M. Horowitz, Thomas C. Shea, Steven M. Devine, Kenneth C. Anderson, Charles Linker
Published 2012Artigo -
9
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy by Jens G. Lohr, Petar Stojanov, Scott L. Carter, Peter Cruz‐Gordillo, Michael S. Lawrence, Daniel Auclair, Carrie Sougnez, Birgit Knoechel, Joshua Gould, Gordon Saksena, Kristian Cibulskis, Aaron McKenna, Michael A. Chapman, Ravid Straussman, Joan Levy, Louise M. Perkins, Jonathan J. Keats, Steven E. Schumacher, Mara Rosenberg, Gad Getz, Todd R. Golub, Kenneth C. Anderson, Paul G. Richardson, Amrita Krishnan, Sagar Lonial, Jonathan L. Kaufman, David S. Siegel, D. H. Vesole, Vivek Roy, Candido E. Rivera, S. Vincent Rajkumar, Shaji Kumar, Rafaël Fonseca, Greg Ahmann, P. Leif Bergsagel, A. Keith Stewart, Craig C. Hofmeister, Yvonne A. Efebera, Sundar Jagannath, Ajai Chari, Suzanne Trudel, Donna Reece, Jeffrey Wolf, Thomas C. Martin, Todd M. Zimmerman, Cara A. Rosenbaum, Andrzej Jakubowiak, Daniel Lebovic, Ravi Vij, Keith Stockerl-Goldstein
Published 2014Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Multiple myeloma
Lenalidomide
Oncology
Transplantation
Adverse effect
Autologous stem-cell transplantation
Biology
Carfilzomib
Coronavirus disease 2019 (COVID-19)
Disease
Immunology
Infectious disease (medical specialty)
Intensive care medicine
Pathology
Surgery
2019-20 coronavirus outbreak
AL amyloidosis
Allele
Alternative medicine
Amyloidosis
Antibody
Astrobiology
Asymptomatic
Bortezomib
Cancer research
Chemotherapy
Clinical endpoint
Clinical trial